Toshio Ohtsubo Selected Research

Toshio Ohtsubo Research Topics

Disease

11	Hypertension (High Blood Pressure) 01/2021 - 07/2006
3	Neoplasms (Cancer) 07/2018 - 07/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2011
3	Hyperthermia 11/2005 - 01/2002
2	Hypoxia (Hypoxemia) 12/2021 - 10/2009
2	Obesity 01/2021 - 01/2014
2	Renal Insufficiency (Renal Failure) 01/2020 - 10/2009
2	Inflammation (Inflammations) 08/2017 - 10/2009
2	Head and Neck Neoplasms (Head and Neck Cancer) 07/2003 - 05/2002
1	Hyperuricemia 12/2021
1	Pulmonary Arterial Hypertension 12/2021
1	Body Weight (Weight, Body) 01/2020
1	Heart Failure 01/2019
1	Myocardial Infarction 01/2019
1	Pathologic Complete Response 07/2018
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 07/2018
1	Cushing Syndrome 07/2018
1	Pheochromocytoma 07/2018
1	Apnea 01/2018
1	Ischemia 08/2017
1	Reperfusion Injury 08/2017
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 09/2016
1	Insulin Resistance 01/2014
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2014
1	Peritoneal Fibrosis 01/2014
1	Ascites 01/2014
1	Proteinuria 01/2014
1	Fibrosis (Cirrhosis) 10/2009
1	Stroke (Strokes) 06/2007
1	Parkinson Disease (Parkinson's Disease) 08/2006
1	Hypertrophy 07/2006
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2006
1	Essential Hypertension 07/2006
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2004
1	Adenoma (Adenomas) 10/2003
1	Squamous Cell Carcinoma of Head and Neck 07/2003
1	Middle Ear Cholesteatoma 05/2003

Drug/Important Bio-Agent (IBA)

5	Uric Acid (Urate)IBA 12/2021 - 07/2006
2	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 01/2012
2	Xanthine DehydrogenaseIBA 08/2017 - 10/2009
2	SaltsIBA 09/2016 - 08/2012
2	LipidsIBA 01/2014 - 10/2009
2	Proteins (Proteins, Gene)FDA Link 06/2007 - 10/2003
2	Complementary DNA (cDNA)IBA 05/2003 - 05/2002
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2021
1	Semaxinib (SU5416)IBA 12/2021
1	Oxonic AcidIBA 12/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	HypoxanthineIBA 01/2020
1	NAD (NADH)IBA 01/2020
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 01/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	Adrenocorticotropic Hormone (ACTH)FDA Link 07/2018
1	CatecholaminesIBA 07/2018
1	GlucocorticoidsIBA 07/2018
1	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2018
1	Metyrapone FDA Link 07/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2018
1	Ion Channels (Ion Channel)IBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	HDL CholesterolIBA 01/2018
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2017
1	Neprilysin (Neutral Endopeptidase)IBA 10/2017
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2017
1	Valsartan (Vals)FDA Link 10/2017
1	Angiotensin II Type 1 Receptor BlockersIBA 10/2017
1	Allopurinol (Remid)FDA LinkGeneric 08/2017
1	3-nitrotyrosineIBA 08/2017
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2017
1	Sodium Chloride FDA LinkGeneric 09/2016
1	Losartan (Cozaar)FDA LinkGeneric 01/2015
1	DiureticsIBA 01/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2014
1	SteroidsIBA 01/2014
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2009
1	purineIBA 10/2009
1	DNA (Deoxyribonucleic Acid)IBA 06/2007
1	8-oxodeoxyguanosine triphosphateIBA 06/2007
1	8-Hydroxy-2'-DeoxyguanosineIBA 06/2007
1	A-Form DNA (A-DNA)IBA 08/2006
1	Mitochondrial DNA (mtDNA)IBA 08/2006
1	EnzymesIBA 08/2006
1	CreatinineIBA 07/2006
1	NF-kappa B (NF-kB)IBA 11/2005
1	Antisense RNA (Anti-Sense RNA)IBA 11/2005
1	histone deacetylase 3IBA 11/2005
1	Histone Deacetylase InhibitorsIBA 11/2005
1	OligonucleotidesIBA 11/2005
1	Neomycin FDA LinkGeneric 07/2004
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 07/2004
1	Thymidine PhosphorylaseIBA 07/2003
1	ThymosinIBA 05/2003

Therapy/Procedure

3	Therapeutics 01/2014 - 11/2005
1	Secondary Prevention 01/2019
1	Adrenalectomy 07/2018
1	Renal Dialysis (Hemodialysis) 01/2014